WPLift-mobile-header-1

Qualigen stock news


Metorik Woocommerce Reports

Marshall as Chief Financial Officer News Real-time exchange rate quote of QUALIGEN THERAPEUTICS INC. Jul 13, 2020 · Qualigen Therapeutics Inc. (NASDAQ:QLGN)’s share price gapped up before the market opened on Tuesday . (QLGN) is up more than 24% at $6. 36. Qualigen […] Get the latest Qualigen Therapeutics, Inc. com. Qualigen […] Aug 05, 2020 · Stock quote and company snapshot for QUALIGEN THERAPEUTICS INC (QLGN), including profile, stock chart, recent news and events, analyst opinions, and research reports. , July 7, 2020 /PRNewswire/ -- Qualigen Therapeutics, Inc. Can you offer me any reason why I would consider keeping my investment with you? Qualigen Therapeutics Receives U. and Qualigen, Inc Since its inception almost 20 years ago, FastPack has generated more than $100 million in commercial sales. C. Announces Stockholder Approval of Proposals Required for Merger Transaction with Qualigen, Inc. - 5/22/2020 12:35:10 PM Registration Pursuant to Securities Act Rule 462(b) of up to an Additional 20% of Securities for an Offering That Was Registe Jul 13, 2020 · About Qualigen Therapeutics, Inc. CARLSBAD, Calif. and other countries around the world. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Jul 07, 2020 · In comparing Qualigen Therapeutics, Inc. Find the latest Dividend Yield (TTM) for Ritter Pharmaceuticals Inc (QLGN) Jul 13, 2020 · What new traders may not know is the stock market is also open for business before and after regular trading hours. , investors would also find a great ally in the technical patterns of the stock movements showed in stock charts. , May 26, 2020 /PRNewswire/ — Qualigen Therapeutics, Inc. CARLSBAD, Calif. 720. historical stock charts and prices, analyst ratings, financials, and today’s real-time QLGN stock price. The QLGN stock was last observed hovering at around $4. (NASDAQ: QLGN) ("Qualigen" or the "Company"), today announced the closing of its previously announced registered direct offering, priced at-the-market under Nasdaq rules, with a single institutional investor for the purchase and sale for $10,000,000 of (i) 1,717,106 shares of common stock and (ii) 1,287,829 common stock Qualigen Therapeutics, Inc. As of now, QLGN has a P/S, P/E and, P/B values of 16. Announces Expected Closing of Merger Transaction with Qualigen, Inc. ,” and is expected to trade on The Nasdaq Capital Market on a post-reverse stock split basis under the new ticker symbol “QLGN” beginning on Tuesday, May 26, 2020. , formerly Ritter Pharmaceuticals, Inc. 82375 ($5. Ritter Pharmaceuticals, Inc. pursuing the business of Qualigen, Inc. Get Qualigen Therapeutics, Inc. The total size of the offering was $11,040,012 based on an initial share price of $9. Advanced Chart, Quote and financial news from the leading provider and award-winning BigCharts. 75. In layman's terms, the QLGN stock price is the highest amount someone is willing to pay for the Qualigen Therapeutics stock, or the lowest amount that it can be bought for. 4, 2020 /PRNewswire/ -- Qualigen Therapeutics, Inc. Horizontal Price levels are working well 2. After the session, the Healthcare sector daily volume shifted […] Jul 06, 2020 · Qualigen Therapeutics, Inc. That rank is influenced by a short-term technical score of 0. The fundamental score for QLGN is 0. and formerly traded under the symbol RTTR), has completed its previously announced merger transaction with Qualigen the stock is 86. (NASDAQ: QLGN) ("Qualigen" or the "Company") announces it has submitted an official notification to the U. Qualigen diagnostics . Globally and locally downtrend 4. (Name of Issuer) Common Stock, $0. Announces $10 Million Registered Direct Offering Priced At-the-Market WFMZ Eastern Pennsylvania and Western New Jersey · 3 days ago. Compared to previous close which recorded 0. , June 10, 2020 /PRNewswire/ -- Qualigen Therapeutics, Inc. Get Qualigen Therapeutics Inc (QLGN:NASDAQ) real-time stock quotes, news and financial information from CNBC. (NASDAQ: QLGN) (Qualigen or the Company) announced today that the United States Patent and Trademark Office has issued a Notice of Allowance for a U. ritter pharmaceuticals inc - will merge with and into qualigen in an all-stock transaction with qualigen. QLGN share price is the price of a single share of a number of saleable stocks of Qualigen Therapeutics, derivative or other financial asset. Get the latest news and breaking stories for Qualigen Therapeutics (QLGN) stock. Therapeutics, Inc. 75 and move down -490. (NASDAQ: QLGN) (Qualigen or the Company) (formerly known as Ritter Pharmaceuticals, Inc. (“Qualigen”), a biotechnology company focused on the development of novel therapeutics for the treatment of cancer and infectious disease, as well as the expansion of its flagship FastPack Qualigen Therapeutics, Inc. MU) stock news and headlines to help you in your trading and investment decisions. (“Ritter Pharmaceuticals”, “Ritter” or the “Company”), announced today that, based upon the final vote count certified by the inspector of election for the special meeting of stockholders held on May 18, 2020, its stockholders approved all of the Qualigen, Inc. , a biotechnology company, develops novel therapeutic products for the treatment of cancer and infectious diseases. The Company is focused on the development and commercialization of therapeutic products for the treatment of cancer and infectious diseases, as well as development of its FastPack diagnostic platform. 07 respectively. category Market News, Morning Market Stats, SPY, and 23 more. Announces $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules. (NASDAQ: RTTR) in a reverse merger with Qualigen, Inc. Qualigen, Inc. Food and Drug Administration ("FDA") to commence sales in the U. 15 and $4. )* Qualigen Therapeutics, Inc. Today 11:09 EDT. QLGN opened at $5. , Inc. , May 26, 2020 /PRNewswire/ -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (“Qualigen” or the “Company”), today announced the closing of its previously announced registered direct offering, priced at-the-market under Nasdaq rules, with a single institutional investor for the purchase and sale for $8,000,000 of (i) 1,140,570 shares of Common Shares, (ii) 780,198 Pre Stock Alert: Qualigen Therapeutics Jumps 60% In View Of COVID-19 Antibodies Test Sales By RTTNews Staff Writer | Published: 7/1/2020 10:13 AM ET Shares of Qualigen Therapeutics, Inc. Over the last 52 weeks, QLGN is down -85. 24% at $4. 19 in pre-market trading on no news, adding to yesterday's gain of 13%. 11% or $0. (QLGN). The trading starts at $4. Qualigen diagnostics May 14, 2020 · About Qualigen, Inc. 75, which means current price is +23. (www. Other News Sources. , June 4, 2020 /PRNewswire/ -- Qualigen Therapeutics, Inc. no rollback 10. 62% higher on its value in year-to-date trading and has touched a low of $3. S. 2, 2020 /PRNewswire/ -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) ("Qualigen" or the "Company") announces it has engaged Pro Football Hall of Fame and College Football Hall of Aug 04, 2020 · [ August 4, 2020 ] Qualigen Therapeutics, Inc. , Aug. 5% of the post-merger combined company on Qualigen Therapeutics, Inc. (NASDAQ:QLGN) marked $5. May 26, 2020 · CARLSBAD, Calif. May 26, 2020 · Common stock begins trading today on NASDAQ under the ticker QLGN. Traders and investors may also choose to study the ATR or Average True Range when concentrating on technical inventory assessment. 0 out of 10, indicating that recent news coverage is unlikely to have an impact on the stock's share price in the immediate future. (QLGN), analysts’ consensus is at an average recommendation of Hold while assigning it a mean rating of 3. At the moment, only 77. plc (NASDAQ:AMRN) was the target of some unusual options trading activity on Wednesday. Aug 03, 2020 · The QLGN stock’s 52-week price range has touched low of $3. 73 per Common Share and $0. and formerly traded under the symbol RTTR), has completed its previously announced merger transaction with Qualigen, Inc. Qualigen Therapeutics, Inc. To add more color to this target, the company’s high over the last year is $31. May 05, 2020 · Ritter Pharmaceuticals, Inc. QLGN's rank also includes a long-term technical score of 0. Over the next 52 weeks, Qualigen Therapeutics Inc has on average historically fallen by 58. (NASDAQ: QLGN) ("Qualigen" or the "Company"), today announced the closing of its previously announced registered direct offering, priced at-the-market under Nasdaq rules, with a single institutional investor for the purchase and sale for $10,000,000 of (i) 1,717,106 shares of common stock and (ii) 1,287,829 common stock Search. qualigeninc. 57 and the avg recommendation for the stock is Hold. Jul 13, 2020 · Current stock quote for Qualigen Therapeutics Inc. To add more color to this target, the company’s high over the last year is $30. The stock has a 52-week high of $31. Yahoo. 28%, in the last five days QLGN remained trading in the green while hitting it’s week-highest on Wednesday, Jul 01 when the stock touched $7. QLGN Stock Message Board for Investors. (NASDAQ:QLGN) ("Qualigen" or the "Company"), today announced it has entered into a definitive agreement with a single institutional investor for the purchase and sale for $10,000,000 of (i) 1,717,106 Common Shares and (ii) 1,287,829 Common Warrants at a combined purchase price of $5. (NASDAQ:QLGN) trade information. 33 percent. In looking, the SMA 200 we see that the stock has seen a -22. 79 on Wednesday. Breaking news and media archive for Qualigen Therapeutics Inc. Aug 06, 2020 · CARLSBAD, Calif. jumped around 0. (QLGN) most recent report reveals some hints about its future - The News Heater Tue, 28 Jul 2020 Jul 01, 2020 · Qualigen Forward-Looking Statements This news release contains forward-looking statements by the Company that involve risks and uncertainties and reflect the Company's judgment as of the date of the stock is 87. , and the Company's common stock will commence trading on the Nasdaq Capital Jul 30, 2020 · Find the latest press releases from Qualigen Therapeutics, Inc. 26 during trading hours on Thursday, reaching $7. Analysts Jul 27, 2020 · Qualigen Therapeutics, Inc. , July 22, 2020 /PRNewswire/ -- Qualigen Therapeutics, Inc. 0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the next few days. Announce Merger Agreement” ” QLGN stock churned in pre-market trading on July 30, 2020, after the company sent out a press release that it was now shipping its FastPack COVID-19 antibody test. 5% of the post-merger combined company on Get the latest Qualigen Therapeutics, Inc. Fund data provided by Xignite and Morningstar. is a biotechnology company focused on developing therapeutics for the treatment of cancer and infectious diseases. , June 10, 2020 /PRNewswire/ — Qualigen Therapeutics, Inc. Aug 05, 2020 · QLGN | Complete Qualigen Therapeutics Inc. When the trading was stopped its value was $5. Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules News [ August 4, 2020 ] Prometheus Biosciences Appoints Keith W. , and will focus on the development of Qualigen’s nanotechnology therapies for the treatment of cancer and infectious Qualigen Therapeutics, Inc. 001 share price. 2 percent, while insider ownership is 0. The London Stock Exchange does not disclose whether a trade is a buy or Feb 27, 2020 · Penny Stocks (PennyStocks. | Investors Hangout As an investor why would I even consider investing in you, Qualigen. May 22, 2020 · Immediately following the closing, Ritter will be renamed “Qualigen Therapeutics, Inc. 79%. (NASDAQ: QLGN) ("Qualigen" or the "Company"), today announced the closing of its previously announced registered direct offering, priced at-the-market under Nasdaq rules, with a single institutional investor for the purchase and sale for $10,000,000 of (i) 1,717,106 shares of common stock and (ii) 1,287,829 common stock Jul 23, 2020 · Qualigen, Inc. (NASDAQ: QLGN) ("Qualigen" or the "Company"), today announced it has entered into a definitive agreement with a single institutional investor for the purchase and sale for $10,000,000 of (i) 1,717,106 Common Shares and (ii) 1,287,829 Common Warrants at a combined purchase price of $5. Used QUALIGEN Fastpack Blood Analyzer For Sale - DOTmed Listing #1885867: QUALIGEN FastPack IP System- Quantitative Immunoassay Analyzer. merger-related proposals, including: (i) the Qualigen Forward-Looking Statements This news release contains forward-looking statements by the Company that involve risks and uncertainties and reflect the Company's judgment as of the date of Review the latest Balance Sheet Statement for QUALIGEN THERAPEUTICS INC (NAQ:QLGN) - including Assets, Liabilities and Equity figures. These statements include those related to potential future development, testing and launch of product candidates. Qualigen Therapeutics Inc. (NASDAQ: QLGN) (Qualigen or the Company) announced today that the Company has released a pre-launch supply of its proposed FastPack ® SARS-CoV-2 IgG Qualigen is an attractive candidate for Ritter, due to its revenue-generating diagnostic business. LOS ANGELES, May 01, 2020 (GLOBE NEWSWIRE) -- Form S-4 Declared Effective by the SEC and Ritter/Qualigen Merger Voting is Underway Jul 10, 2020 · CARLSBAD, Calif. stock is now 8. 35 percent. Announces Stockholder Approval Of Proposals Required For Merger Transaction With Qualigen, Inc. The stock had previously closed at $5. (QLGN) shares are trading at higher $4. 2020-05-01 17:35 ET - News Release. ," and is expected to trade on The Nasdaq Capital Market on a post-reverse stock split basis under the new ticker symbol "QLGN" beginning on Tuesday, May 26, 2020. Investment News. Reed Smith advised Ritter Pharmaceuticals, Inc. 18% above from all time high which was touched on 03/02/20. The company's cancer therapeutics pipeline includes ALAN (AS1411-GNP), RAS-F3 and STARS™. Qualigen Therapeutics had issued 1,226,668 shares in its IPO on June 30th. Collection of curated The combined company will operate under the name Qualigen Therapeutics, Inc. The stock SMA50 is now at -15. (NASDAQ:QLGN) Trading Ideas and Stock Summary All · Charts · Sentiment · News · Trading Stats · Key Ratios · FAQ Charts for Today's Stock Price and Implied Volatility in Qualigen Therapeutics Inc. , and the Company's common stock will commence trading on the Nasdaq Capital CARLSBAD, Calif. Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation Jul 13, 2020 · Qualigen Therapeutics Inc. On Monday, shares of Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (Qualigen or the Company) announced today it has begun commercial shipments of its FastPack ® SARS-CoV-2 IgG diagnostic test for COVID-19 antibodies. (NASDAQ: QLGN) ("Qualigen" or the "Company"), today announced it has entered into a definitive agreement with a single May 14, 2020 · LOS ANGELES (April 16, 2020) – Ritter Pharmaceuticals, Inc. 07% for the month. May 26, 2020 · The combined company will operate under the name Qualigen Therapeutics, Inc. Qualigen valuation May 05, 2020 · Penny Stocks (PennyStocks. (Nasdaq: RTTR) (“Ritter Pharmaceuticals”, Ritter” or the “Company”), a developer of therapeutic products that modulate the gut microbiome to treat gastrointestinal diseases, today reported financial results for the first quarter ended March Amarin Co. - GlobeNewswire Thu, 14 May 2020 Ritter Pharmaceuticals, Inc. com) is a biotechnology company focused on developing novel therapeutics for the treatment of cancer and infectious diseases, using similar CARLSBAD, Calif. 06-01 sec. (NASDAQ: QLGN) ("Qualigen" or the "Company"), today announced it has entered into a definitive agreement with Jan 21, 2020 · On a pro forma basis and based on the number of shares of Ritter Pharmaceuticals common stock to be issued in the merger, the pre-merger Ritter Pharmaceuticals stockholders will own approximately 7. , July 1, 2020 /PRNewswire/ --Qualigen Therapeutics, Inc. StockHouse. The level is confirmed by many touches and a false breakout 5. , June 2, 2020 /PRNewswire/ -- Qualigen Therapeutics, Inc. 73 per Common Share and $0 Unique to Barchart. (NASDAQ: QLGN) ("Qualigen" or the "Company"), today announced it has entered into a definitive agreement with a single institutional investor for the purchase and sale for $8,000,000 of (i) 1,200,000 Common Shares, (ii) 780,198 Pre-Funded Warrants and (iii) 1,980,198 Common Warrants at a combined purchase price of $4 Ritter Pharmaceuticals Expects Merger With Qualigen Top Submitted by News Staff on Fri, 05/22/2020 - 13:28 Ritter Pharmaceuticals (NASDAQ:RTTR) has announced that it expects the pending merger with Qualigen to close after market hours today, May 22, 2020. 6 percent. Shares of Amarin stock traded up $0. 00. I think that actual news will saying "Merger with Qualigen finalized" will boost it. BE). stock, an investor will come to know that the weekly performance for this stock is valued at 21. Qualigen valuation Qualigen Therapeutics, Inc. 78% of loss with the last five trading sessions. Aug 04, 2020 · CARLSBAD, Calif. 6, 2020 /PRNewswire/ -- Qualigen Therapeutics, Inc. During Qualigen Therapeutics’ quiet period, insiders and any underwriters involved in the IPO are […] Apr 28, 2020 · Qualigen, Inc. 27 and closed at $4. Company News for May 26, 2020 Companies In The News Are: TTWO, XERS, SPLK, NAVB: Tue, 26 May 2020 12:58:12 +0000: Is the Options Market Predicting a Spike in T2 Biosystems (TTOO) Stock? Investors need to pay close attention to T2 Biosystems (TTOO) stock based on the movements in the options market lately. (NASDAQ: QLGN) (Qualigen or the Company) announced today that it will host a business update conference call and live CARLSBAD, Calif. com) is the top online destination for all things Micro-Cap Stocks. 's stock price today. , July 10, 2020 /PRNewswire/ -- Qualigen Therapeutics, Inc. (QLGN) surged 60% on Wednesday morning after the company said it submitted an official notification to the FDA to commence sales in the U. Announces $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules PR Newswire Legend Biotech Announces Preliminary Results for First Half of 2020 CARLSBAD, Calif. Upon completion of the merger, Ritter will change its name to Qualigen Therapeutics, Inc. (NASDAQ:QLGN) went up by 35. 75 and the low is $3. (NASDAQ: QLGN) ("Qualigen" or the "Company"), today announced the closing of its previously announced registered direct offering, priced at-the-market under Nasdaq rules, with a single institutional investor for the purchase and sale for $10,000,000 of (i) 1,717,106 shares of common stock and (ii) 1,287,829 common stock Aug 02, 2020 · CARLSBAD, Calif. com) is a biotechnology company focused on developing novel therapeutics for the treatment of cancer and infectious diseases, using similar core nanoparticle coating technology from its FDA-approved FastPack ® System, which has been used successfully in diagnostics for over 15 years. 89 per share versus a previous $6. 11 and day high was $4. Get detailed information on QUALIGEN THERAPEUTICS INC (QLGN. 40 per share. Announces $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules Qualigen valuation. 71. The stock has a […] Get Stock & Bond Quotes, Trade Prices, Charts, Financials and Company News & Information for OTCQX, OTCQB and Pink Securities. (US:QLGN) instituional ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. no energy, but maybe a good countertrend move 9. More Headlines » Capital Structure May 26, 2020 · Common stock begins trading today on NASDAQ under the ticker QLGN Company raises $4 million in a private placement . (NASDAQ: QLGN) ("Qualigen" or the "Company"), today announced the closing of its previously announced registered direct offering, priced at-the-market under Nasdaq rules, with a single institutional investor for the purchase and sale for $10,000,000 of (i) 1,717,106 shares of common stock and (ii) 1,287,829 common stock Aug 07, 2020 · Qualigen Therapeutics, Inc. 78, with a volume of 142,373 shares. stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. 13%, resulting in a performance for the month at 45. (QLGN) shares are trading at lower $5. Qualigen’s FastPack ® System provides real-time diagnostics for cancer and other diseases at medical offices in the U. During the company’s quiet period, insiders and underwriters involved in the IPO […] See Qualigen Therapeutics price target based on analysts offering 12 month price targets for Qualigen Therapeutics in the last 3 months. Jul 07, 2020 · CARLSBAD, Calif. (NASDAQ:QLGN) changes shares on Friday trading session, with a change of 4. Market Insider is a business news aggregator for traders and investors that proposes to you the latest financial markets news, top stories headlines and trading analysis on stock market, currencies (Forex), cryptocurrency, commodities futures, ETFs & funds, bonds & rates and much more. Thu, 30 Jul 2020 Should You Buy Qualigen Therapeutics Inc (QLGN) Stock After it Is Higher By 30. Announces $10 Million Registered Direct Offering Priced At-the Top News Videos for stock market news today. (NASDAQ: QLGN) established initial surge of 13. 21 shares. Aug 02, 2020 · CARLSBAD, Calif. com you will find a comprehensive list of Penny Stocks & discover the best Penny Stocks to buy, top penny stock news and micro-cap stock articles. Pre- and post-market trading sessions allow investors to trade stocks between This list of companies and startups in Carlsbad, California provides data on their funding history, investment activities, and acquisition trends. On PennyStocks. (NASDAQ: QLGN) (Qualigen or the Company) announced today the signing of an exclusive worldwide license agreement with announce merger agreement. Securities and Exchange Commission (the “SEC”) has declared effective its Registration Statement on Form S-4 relating to its previously announced proposed merger with Qualigen, Inc. 96. 40. : News, information and stories for QUALIGEN THERAPEUTICS, INC. It offers FastPack, a rapid diagnostic testing system; ALAN, a DNA coated gold nanoparticle cancer drug candidate that targets various cancers; AS1411 for treating viral-based infectious diseases; RAS-F3, a small-molecule RAS oncogene protein-protein inhibitor that Jul 02, 2020 · The Qualigen Therapeutics Inc. stock news by MarketWatch. In looking, the SMA 200 we see that the stock has seen a -14. 78% from its latest closing price when compared to the 1-year high value of $30. The Jul 31, 2000 · CEO SUMMARY: Qualigen, Inc. 4995 before settling in for the price of $4. (NASDAQ: QLGN) (Qualigen or the Company) announced today the signing of an exclusive license agreement with the University of Louisville (UofL) to facilitate development of Qualigen's AS1411 DNA aptamer as a drug candidate for the treatment of COVID-19, the disease caused by the novel coronavirus SARS-CoV-2. . 96, as the Stock market unbolted on July 20, 2020. 94 on the day. QLGN--0. company facts, information and stock details by MarketWatch. Financial Focus for Why Qualigen's Stock Trading Higher Today. 57 at the close of the session, up 15. The stock has traded between $4. (NASDAQ: QLGN) (Qualigen or the Company) announced today the signing of an exclusive license agreement with the University of Louisville (UofL) to facilitate development of Qualigen’s AS1411 DNA aptamer as a drug candidate for the treatment of COVID-19, the disease caused by the novel coronavirus SARS-CoV-2. 490% QLGN / Qualigen Therapeutics, Inc. is a medical device company focused on the development, production and commercialization of innovative medical technologies, including novel therapeutic technologies for treatment Qualigen Therapeutics Inc. is a biotechnology company focused on developing novel therapeutics for the treatment of cancer and infectious diseases, as well as maintaining and expanding its core FDA-approved FastPack System, which has been used successfully in diagnostics for almost 20 years. Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Features One-Touch Operation in Delivering Values for Breaking news and media archive for Qualigen Therapeutics Inc. 71 and a one year high of $30. (QLGN) Stock Price for pre-market, after-hours and regular trading sessions in a minute-by-minute Volume-Weighted Average Price (VWAP) table. 45 and closed at $3. of the Company's FastPack ® SARS-CoV-2 IgG test for COVID-19 antibodies. , is a biotechnology company. gained FDA approval to sell its FastPack™ System for PSA testing in the United States. Find out the direct holders, institutional holders and mutual fund holders for QUALIGEN THERAP. 88) 2021 forecasted earnings estimate for the year ending December 31, 2021 has been reduced. Qualigen is one more example of a technology company that expects to shift diagnostic testing out of core laboratories and closer to the patient. Jun 11, 2020 · For Qualigen Therapeutics, Inc. Announces $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules Article Stock Quotes (1) FREE Breaking News Alerts from StreetInsider. Results are interpreted as buy, sell or hold signals, each with numeric ratings and summarized with an overall percentage buy or sell rating. (NASDAQ: QLGN) is 5. 00%--Why Qualigen's Stock Trading Higher Today. The market seems to go up, mainly based on the merger with Qualigen - ( I did not find any other news regarding this stock) Qualigen should become a wholly-owned subsidiary of Ritter. (NASDAQ:QLGN) shares gapped up prior to trading on Tuesday . Stock Price, News and Company Updates. Qualigen Therapeutics had issued 1,226,668 shares in its initial public offering on June 30th. This is an increase of 741% compared to the average volume of 801 put options. , and will focus on the development of Qualigen’s nanotechnology therapies for the treatment of cancer and infectious May 27, 2020 · Lotz Christopher L. The stock, however, witnessed a rise in its short on 05/15/20. peers and a company profile. The trading starts at $6. They also gave media headlines about the company a news buzz of 0. 71 and a high of $30. 5% of the post-merger combined company and the pre-merger Qualigen stockholders will own approximately 92. The 1-year high price for the company’s stock is recorded $21. 75 high. will be a wholly-owned subsidiary of Qualigen Therapeutics, Inc. 15%, while QLGN stocks collected +21. shares were sold CARLSBAD, Calif. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA), and earlier this month Qualigen Therapeutics Inc Stock Forecast. Jul 24, 2020 · The stock remained 12. 86% in a Week? - InvestorsObserver Thu, 30 Jul 2020 Qualigen Therapeutics Begins Shipping FastPack® COVID-19 Antibody Test - Yahoo Finance Wed, 29 Jul 2020 Qualigen Therapeutics, Inc. Aug 06, 2020 · Qualigen Therapeutics Inc. Do you have anything scheduled in the very near future to help re build our confidence with Qualigen. , a company focused on the development of novel therapeutic products for the treatment of cancer and sharewise - Stocks and the Wisdom of the crowd. (NASDAQ: QLGN) (Qualigen or the Company) announced today it has begun commercial shipments of its FastPack ® SARS-CoV-2 Jan 21, 2020 · Management and Organization. 50 and lowest of $4. 00:39. Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules Qualigen Therapeutics shares are trading lower after the company announced a $10 million registered direct offering. of the Company's FastPack® SARS-CoV-2 May 22, 2020 · Immediately following the closing, Ritter will be renamed “Qualigen Therapeutics, Inc. 8 on InfoTrie's scale. 5% of the post-merger combined company on Webull offers kinds of Qualigen Therapeutics Inc stock information, including NASDAQ:QLGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, QLGN stock news, and many more online research tools to help you make informed decisions. (Nasdaq: RTTR) (“Ritter Pharmaceuticals”, Ritter” or the “Company”), a developer of therapeutic products that modulate the gut microbiome to treat gastrointestinal diseases, today announced that the U. View the latest news about Qualigen. Recently in News on August 2, 2020, Qualigen Therapeutics, Inc. 55 at the close. Announces $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules PR Newswire CARLSBAD, Calif. (Nasdaq: RTTR) (“Ritter Fri, 22 May 2020 Ritter Pharmaceuticals, Inc. Jan 21, 2020 · On a pro forma basis and based on the number of shares of Ritter Pharmaceuticals common stock to be issued in the merger, the pre-merger Ritter Pharmaceuticals stockholders will own approximately 7. 4%) announces a reverse merger with privately held Qualigen, a developer of therapies for cancer and infectious diseases. View real-time stock prices and stock quotes for a full financial overview. View the latest news about Qualigen Therapeutics. NQ) including stock quotes, financial news, historical charts, company background, company fundamentals, company financials, insider trades, annual reports and historical prices in the Company Factsheet. 73 per Common Share and $0 Apr 28, 2020 · April 28 (Reuters) - Ritter Pharmaceuticals Inc: * RITTER PHARMACEUTICALS, INC. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 061 before settling in for the price of $5. During Qualigen Therapeutics’ quiet period, insiders and any underwriters that worked on the IPO […] Qualigen Therapeutics Inc. After the consummation of the tie-up Aug 06, 2020 · Qualigen Therapeutics Inc (QLGN) stock is trading at $4. 88 and last traded at $5. stock and Biotechnology market discussion, news, and analysis from Canada's largest community of active investors Jul 22, 2020 · Qualigen (NASDAQ:QLGN) was upgraded by equities researchers at ValuEngine from a “buy” rating to a “strong-buy” rating in a research report issued to clients and investors on Wednesday, ValuEngine reports. May 26, 2020 · Immediately prior to and in connection with the merger, Qualigen Inc. Market data provided by Xignite. Splitting up the data highlights that, out of 1 analysts covering the stock, none rated the stock as a Sell while none recommended an Overweight rating for the stock. (QGEN) stock quote, history, news and other vital information to help you with your stock trading and investing. Historical Performance In The News: Taking a look at the performance of Qualigen Therapeutics, Inc. 64 respectively. 73 per Common Share and $0 RTTR stock quote, chart and news. Discover QLGN stock charts, view historical QLGN stock prices and see why Qualigen Therapeutics (QLGN) is trading at $5. 82 million, a P/E ratio of -0. Review the latest Balance Sheet Statement for QUALIGEN THERAPEUTICS INC (NAQ:QLGN) - including Assets, Liabilities and Equity figures. 75 and a 52-week low of $3. Company raises $4 million in a private placement. 13%, as 1. In the face of being in the red today for losing -10. (NASDAQ: QLGN) (Qualigen or the Company) announced today that the Company has released a pre-launch supply of its proposed FastPack ® SARS-CoV-2 IgG Immunoassay diagnostic test kits to the University of Louisville to conduct validation studies with hundreds of patient samples, as well as for use in research on COVID-19. As previously announced, Ritter’s stockholders voted to approve the proposals required to complete the merger transaction, including a reverse stock split within a range of 1-for-25 to 1-for-35, as determined by Ritter’s board of directors. 75: qlgn is down -46% since the beginning of the year: qlgn is down -46% over the past 12 months: qlgn is down -15% over the past 1 month: n/a% of all qlgn investors are betting against qlgn: num investors short qlgn has gone up 134% versus last month Aug 06, 2020 · CARLSBAD, Calif. Following the merger, Michael S. They also assigned media coverage about the company a news buzz of 10. 75 for the year while the low is $3. 23% over the past 12 months is in competing position with that of Zoetis Inc Cl A (ZTS) which saw its stock price raised by 0. 78 so far today. 31 with its price kept floating in the range of $5. (NASDAQ: QLGN) ("Qualigen" or the "Company"),today announced it has entered into Aug 02, 2020 · Qualigen Therapeutics, Inc. 91%, while QLGN stocks collected -12. Jun 02, 2020 · On Monday, shares of Qualigen Therapeutics, Inc. 35 and a beta of […] Qualigen Therapeutics, Inc. 7. Announces $8 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - Qualigen, Inc. Ritter Pharmaceuticals is a developer of therapeutic products that modulate the gut microbiome to treat gastrointestinal diseases. 02% off its average median price Qualigen Therapeutics Inc. 40% while the S&P 500 is up 0. 73 per Common Share and $0 Qualigen, Inc. ,” and is expected to trade on The Nasdaq Capital Market on a post-reverse stock split basis under the new Breaking News: Todos Medical Appoints Dr. The combined company will operate under the name Qualigen Therapeutics, Inc. 68% loss, an insight into the fundamental values of Qualigen Therapeutics, Inc. , and the Company's common stock will Ritter Pharmaceuticals, Inc. (“Qualigen”) pursuant to the May 14, 2020 · About Qualigen, Inc. This news release contains forward-looking statements by the Company that involve risks and uncertainties and reflect the Company's judgment as of the date of Jul 22, 2020 · CARLSBAD, Calif. (QLGN) stock price, news, historical charts, analyst ratings and financial information from WSJ. 34% volatile for the week and 15. from the level was made a new high 6. Announces $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules PR 02/08/2020 21:47:44 Cookie Policy +44 (0) 203 8794 460 Free Membership Login May 05, 2020 · RTTR Ritter Pharmaceuticals merger with Qualigen may cause RTTR to sell more stock or Reverse Split? The merger scheduled for 05-14-2020 may be a catalyst for price action or a Reverse Stock Split Jul 01, 2020 · QLGN stock moved higher in early trading on July 1, 2020, after the company announced its FastPack COVID-19 antibody test. Jorge Leon as Consulting Chief Medical and Scientific Officer of Infectious Disease and Oncology Ritter Pharmaceuticals, Inc. Newsroom articles are published by leading news agencies. - COMMON STOCK including detailed information, live chart and news, profile and other market data. 95, 0, and 39. Separately, ValuEngine raised Qualigen […] Ritter Pharmaceuticals, Inc. Find the latest Qualigen Therapeutics, Inc. Its P/Cash is valued at 0. (NASDAQ:QLGN) changes shares on Wednesday trading session, with a change of 15. DL-,001 (7R9B. Message Board Total Posts: 15 Jul 10, 2020 · CARLSBAD, Calif. QLGN Stock saw the intraday high of $7. Common Stock (QLGN) at Nasdaq. Aug 03, 2020 · Qualigen Therapeutics’ (NASDAQ:ADTX) quiet period is set to end on Monday, August 10th. It offers FastPack, a rapid diagnostic testing system; ALAN, a DNA coated gold nanoparticle cancer drug candidate that targets various cancers; AS1411 for treating viral-based infectious diseases; RAS-F3, a small-molecule RAS oncogene protein-protein inhibitor that Qualigen Therapeutics Inc. Jun 26, 2020 · Qualigen Therapeutics Inc. 27, but opened at $4. 50-4 price level, adding 45. 56 as of 1:24 PM on Monday, Jun 29, an increase of $0. 320,105 shares […] Company News for May 26, 2020 Companies In The News Are: TTWO, XERS, SPLK, NAVB: Tue, 26 May 2020 12:58:12 +0000: Is the Options Market Predicting a Spike in T2 Biosystems (TTOO) Stock? Investors need to pay close attention to T2 Biosystems (TTOO) stock based on the movements in the options market lately. Qualigen Therapeutics Inc Change company Symbol lookup Jun 10, 2020 · CARLSBAD, Calif. Immediately following the closing, Ritter will be renamed "Qualigen Therapeutics, Inc. 13,363 people own Qualigen Therapeutics on Robinhood on August 6, 2020. Tue, 19 May 2020 12:30:10 +0000 Evoke Pharma's 2021 Earnings Projection Reduced 4:10AM ET 3/25/2020 MT Newswires. (NASDAQ: QLGN) ("Qualigen" or the "Company"), today announced the closing of its previously announced registered direct offering, priced at-the-market under Nasdaq rules, with a single institutional investor for the purchase and sale for $10,000,000 of (i) 1,717,106 shares of common stock and (ii) 1,287,829 common stock QLGN - Qualigen Therapeutics Inc. , Aug. 12. Get daily stock ideas top-performing Wall Street analysts. Jun 02, 2020 · CARLSBAD, Calif. 50 on Wednesday, July 01. Evoke Pharma Inc's (NASDAQ:EVOK, Recent Price: 0. completed a private placement of preferred stock to an institutional investor resulting in gross proceeds of approximately $4 million in exchange for convertible preferred shares and warrants. Announces Mar 31, 2020 · Form S-4 Declared Effective by the SEC and Ritter/Qualigen Merger Voting is Underway. During the day, the stock rose to $5. Dive deeper with interactive charts and top stories of QUALIGEN THERAPEUTICS, INC. Seeking Alpha. View qlgn business summary and other industry information. com) is a biotechnology company focused on developing novel therapeutics for the treatment of cancer and infectious diseases, using similar core nanoparticle coating technology from its FDA-approved FastPack® System, which has been used successfully in diagnostics for over 15 years. Dow Jones, a News Corp company May 22, 2020 · Immediately following the closing, Ritter will be renamed “Qualigen Therapeutics, Inc. (QLGN) shares reached a high of $5. With having a -8. 97 throughout the day. 21 (4. 2020 is expected to be a huge year for penny stocks. Qualigen shares last traded at $5. 8% of Qualigen's outstanding common shares. 45 closing price. 8% on Tuesday. There wasn't any negative news prior to this merger yet a complete de evaluation. 96 and sunk to $4. 67 and sunk to $5. Live Discussion of QLGN: Stock Chart Yahoo Stock Chart Company News Qualigen Therapeutics, Inc. GlobeNewswire Inc. stock and Biotechnology market discussion, news, and analysis from Canada's largest community of active investors Qualigen, Inc. Aug 06, 2020 · Qualigen Therapeutics Inc stock is lower by -78. was a distant test, touched the level 7. 0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the stock's share price in the near future. (NASDAQ:QLGN)’s share price fell 5. com, Opinions analyzes a stock or commodity using 13 popular analytics in short-, medium- and long-term periods. 8% during mid-day trading on Tuesday . and formerly traded under the symbol RTTR), has completed its previously announced merger transaction with Qualigen Qualigen Therapeutics, Inc. 42% to $5. QLGN Healthcare Biotechnology Qualigen Therapeutics Inc is a biotechnology company focused on the development and commercialization of novel therapeutic products for the treatment of cancer and infectious diseases using nanoparticle coating technology. and formerly traded under the Jan 21, 2020 · On a pro forma basis and based on the number of shares of Ritter Pharmaceuticals common stock to be issued in the merger, the pre-merger Ritter Pharmaceuticals stockholders will own approximately 7. 9 M shorted shares, the short percentage went higher by 53. gov - 1 - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. 40 and day high was $7. The trading session low price was $4. had a pretty Dodgy run when it comes to the market performance. [QLGN] Notifies FDA to begin Distribution of FastPack® COVID-19 Antibody Test as Its Market Cap reaches 61. (NASDAQ: QLGN) open the trading on July 27, 2020, with a bit cautious approach as it glided -3. Jun 10, 2020 · Qualigen Forward-Looking Statements. QUALIGEN THERAPEUTICS, INC. recently reported it has entered into a definitive reverse merger agreement with Qualigen, Inc. Tue, 19 May 2020 12:30:10 +0000 Jul 31, 2000 · CEO SUMMARY: Qualigen, Inc. Jul 01, 2020 · Find the latest news headlines from Qualigen Therapeutics, Inc. Dividend Yield (TTM) is a widely used stock evaluation measure. Follow QLGN to track price target and stock forecast updates from top wall street analysts. V. (Nasdaq: RTTR) (“Ritter Pharmaceuticals”, “Ritter” or the “Company”), is urging its stockholders to vote now on the proposed merger with Qualigen, Inc. URGES STOCKHOLDERS TO VOTE NOW ON PROPOSED MERGER WITH BIOTECH COMPANY, QUALIGEN INC. (NASDAQ: QLGN) ("Qualigen" or the "Company"), today announced the closing of its previously announced registered direct offering, priced at-the-market under Nasdaq rules, with a single institutional investor for the purchase and sale for $8,000,000 of (i) 1,140,570 shares of Common Shares, (ii) 780,198 Pre-Funded Qualigen Therapeutics, Inc. Find the latest Qiagen N. 13, 0, and 36. 1. , a privately held company, in an all-stock transaction. , a company focused on the development of novel therapeutic products for the treatment of cancer and infectious diseases, as well as the worldwide sales of QLGN Stock News & Recent Headlines Qualigen Therapeutics, Inc. Related Links: Jul 21, 2020 · Qualigen Therapeutics Inc. 73 per… Jun 10, 2020 · CARLSBAD, Calif. 25 throughout the day. Initially Qualigen will sell this system to urologists, where it believes the … Qualigen’s POL PSA Test Cleared for Sale by FDA View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. 46% of Qualigen Therapeutics Inc. Start your free trial today for full access. Jun 10, 2020 · Qualigen Therapeutics shares are trading up 6. Qualigen Therapeutics (NASDAQ: QLGN) shares are trading higher on Wednesday, after the company signed an Get the latest QUALIGEN THERAP. 1 day 2 days 5 days 10 days ---------- 1 month 2 months 3 months 6 months YTD 1 year 2 years 3 years 4 years 5 years 1 decade All Data Basic Chart Advanced Chart View today's stock price, news and analysis for Qualigen Therapeutics Inc. The stock has a market cap of $77. and formerly traded under the symbol RTTR), has completed its previously announced merger transaction with Qualigen Therapeutics, Inc. Patent Notice of Allowance for its STARS™ Technology PR Newswire (US) - 6/4/2020 8:00:00 AM Qualigen Therapeutics Releases FastPack® SARS-CoV-2 Antibody Diagnostic Test to University of Louisville to Conduct Validati Jul 06, 2020 · Qualigen Therapeutics, Inc. 94% or $0. 46 in the recent trading session, with the current gains setting it 0. During the day, the stock rose to $4. stock, an investor will come to know that the weekly performance for this stock is valued at 16. Aug 02, 2020 · Qualigen Therapeutics, Inc. as an interesting stock but before investments are made there, an in-depth look at its trading activities will have to be conducted. Qualigen has a one year low of $3. Separately, ValuEngine upgraded shares of Qualigen from a “buy” rating to a “strong-buy” rating in a report on Wednesday. (“Qualigen”), a biotechnology company focused on the development of novel therapeutics for the treatment of cancer and infectious disease, as well as the expansion of its flagship FastPack® point-of-care diagnostic platform. 75 in the current 52-week trading range. dominated the market today, gaining €0. , July 10, 2020 /PRNewswire/ — Qualigen Therapeutics, Inc. 16, or 3. The Jul 01, 2020 · Qualigen Forward-Looking Statements This news release contains forward-looking statements by the Company that involve risks and uncertainties and reflect the Company’s judgment as of the date of this release. In addition, they are developing nanotechnology therapies for the treatment of cancer Qualigen Therapeutics’ (NASDAQ:ADTX) quiet period is set to expire on Monday, August 10th. (NASDAQ:QLGN) went down by -5. In depth view into QLGN (Qualigen Therapeutics) stock including the latest price, news, dividend history, earnings information and financials. 71 for the same time period, recorded on 06/30/20. 99 on Wednesday. 2, 2020 CARLSBAD, Calif. The company traded as low as $4. 88 until finishing in the latest session at $5. 1 day 2 days 5 days 10 days ---------- 1 month 2 months 3 months 6 months YTD 1 year 2 years 3 years 4 years 5 years 1 decade All Data Basic Chart Advanced Chart Jul 23, 2020 · Qualigen, Inc. Jul 01, 2020 · Qualigen Therapeutics, Inc. The company's cancer therapeutics pipeline includes Quotes delayed at least 15 minutes. ritter pharmaceuticals inc - upon completion of merger, company Jun 04, 2020 · Qualigen Therapeutics, Inc. 55% from the previous closing price of $4. Aug 04, 2020 · Recent News View All News Aug 4, 2020 4:05pm EDT Qualigen Therapeutics, Inc. CLOSE ' Stradling Jan 24, 2020 · agreement announce business company inc incorporated merger pharmaceutical qualigen reverse ritter rttr stock One comment on “ “Ritter Pharmaceuticals, Inc. 61 and $5. Biotechnology Qualigen Therapeutics Receives U. News. 70%. 46% and that of -84. 33% to its value on the day. 88 and 5Y monthly beta was reading -0. 71% over the last 12 months. Benzinga Newsdesk Mon, 03 Aug 2020 06:18:47 -0400; Qualigen Therapeutics Prices The stock remained 19. * qualigen - has held an exclusive license to as1411 for all fields of use since 2018. Apr 28, 2020 · Qualigen is an attractive candidate for Ritter, due to its revenue-generating diagnostic business. TICKERS QLGN. 10, with a volume of 2,446,800 shares trading hands. 3 on InfoTrie's scale. Stock traders bought 6,738 put options on the stock. May 19, 2020 · LOS ANGELES, May 19, 2020 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. This test has been submitted to the U. (NASDAQ: QLGN) (Qualigen or the Company), today announced the closing of its previously announced registered direct offering, priced at-the-market under Nasdaq rules, with a single institutional investor for the purchase and sale for $8,000,000 of (i) 1,140,570 shares of Common Shares, (ii) 780,198 Pre-Funded Warrants and (iii) 1,920,768 Common Warrants at a May 01, 2020 · Qualigen Therapeutics, Inc. 50 on Friday, July 10. Aug 03, 2020 · The Qualigen Therapeutics Inc. Jul 29, 2020 · Qualigen Therapeutics, Inc. of its COVID-19 Company profile for Qualigen Therapeutics Inc. LOS ANGELES (May 1, 2020) – Ritter Pharmaceuticals, Inc. Announces $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules Qualigen is actually a pretty big company. The May 24, 2020 · Learn which company shares are splitting and when in this stocks splits calendar from Yahoo Finance. Jul 21, 2020 · Qualigen, Inc. Weaker than the market 3. Taking a look at stock we notice that its last check on previous day was $5. Silicon Investor. After the session, the Healthcare sector daily volume shifted […] Feb 04, 2020 · Qualigen, Inc. ,” and is expected to trade on The Nasdaq Capital Market on a post-reverse stock split basis under the new Jul 24, 2020 · Qualigen (NASDAQ:QLGN) was upgraded by ValuEngine from a “buy” rating to a “strong-buy” rating in a report issued on Wednesday, ValuEngine reports. Includes articles, videos and real-time news from StockTwits. 73 per Common Share and $0 Qualigen Therapeutics, Inc. 73 per Common Share and $0 Qualigen Therapeutics earned a coverage optimism score of 0. Qualigen's worldwide distributor for FastPack is Sekisui Diagnostics, a subsidiary of a multibillion-dollar Japanese chemical and technology company. (QLGN)’s stock with other industry players reveals that stock’s latest price change of -1. The stock SMA50 is now at -12. , July 8, 2020 /PRNewswire/ -- Qualigen Therapeutics, Inc. 35 during the trading on the day. Analysts' recommendations provided by ZACKS Investment Research, Inc. 72. - GlobeNewswire Tue, 19 May 2020 Ritter Pharmaceuticals, Inc. 6 shares. 52% from its latest closing price when compared to the 1-year high value of $31. 38 at the close. (NASDAQ: QLGN) (Qualigen or the Company), today announced it has entered into a definitive agreement with a single institutional investor for the purchase and sale for $10,000,000 of (i) 1,717,106 Common Shares and (ii) 1,287,829 Common Warrants at a combined purchase price of $5. In addition, they are developing nanotechnology therapies for the treatment of cancer Qualigen Therapeutics Inc. , June 10, 2020 /PRNewswire/ --Qualigen, Inc. patent, which Qualigen valuation. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. (QLGN) stock news and headlines to help you in your trading and investment decisions. Initially Qualigen will sell this system to urologists, where it believes the … Qualigen’s POL PSA Test Cleared for Sale by FDA Jul 13, 2020 · What new traders may not know is the stock market is also open for business before and after regular trading hours. 19M Misty Lee - July 2, 2020 0 Qualigen Therapeutics Inc. Stock Ideas and Recommendations. 38M LPI shares were shorted. Basic Chart, Quote and financial news from the leading provider and award-winning BigCharts. com! Jul 02, 2020 · Qualigen Therapeutics Inc. An increase of 57% from the average session volume of 1,068,577 shares. 61% while the S&P 500 is up 0. 11%. 68% in the recent trading and went through an increase of 19. the instrument closed far from Company profile. institutional ownership is standing at 0. Jan 21, 2020 · About Qualigen, Inc. Over the last 52 weeks, QLGN is down -81. , July 30, 2020 /PRNewswire/ -- Qualigen Therapeutics, Inc. 12% at $5. ,” and is expected to trade on The Nasdaq Capital Market on a post-reverse stock split basis under the new View Qualigen Therapeutics Inc. It offers FastPack, a rapid diagnostic testing system; ALAN, a DNA coated gold nanoparticle cancer drug candidate that targets various cancers; AS1411 for treating viral-based infectious diseases; RAS-F3, a small-molecule RAS oncogene protein-protein inhibitor that Qualigen Therapeutics’ (NASDAQ:ADTX) quiet period will end on Monday, August 10th. The company’s 52-week high price is 31. 5% away from all-time highs of $31. Qualigen Therapeutics story: Exercise or conversion by Steven Stein of 7495 shares of Incyte subject to Rule 16b 3 and other headlines for Qualigen Therapeutics Jun 03, 2020 · Qualigen Therapeutics, Inc. 72 at time of publication on Wednesday. "how's the stock market look Description. GlobeNewswire (Fri, May 22, 2020) Jul 08, 2020 · CARLSBAD, Calif. The stock has a […] QLGN - Qualigen Therapeutics Inc. NASDAQ: QLGN price today. It offers FastPack, a rapid diagnostic testing system; ALAN, a DNA coated gold nanoparticle cancer drug candidate that targets various cancers; AS1411 for treating viral-based infectious diseases; RAS-F3, a small-molecule RAS oncogene protein-protein Jul 22, 2020 · Qualigen (NASDAQ:QLGN) was upgraded by equities researchers at ValuEngine from a “buy” rating to a “strong-buy” rating in a research report issued to clients and investors on Wednesday, ValuEngine reports. 72 and the avg recommendation for the stock is Hold. QLGN 08/07/2020 21:32:29 1-888-992-3836 Free Membership Login Jul 21, 2020 · Qualigen Therapeutics Inc. QLGN - Qualigen Therapeutics Inc. 05, 1,676,206 shares were traded during mid-day trading. (NASDAQ: QLGN) ("Qualigen" or the "Company"), today announced it has entered into a definitive agreement with a single institutional investor for the purchase and sale for $10,000,000 of (i) 1,717,106 Common Shares and (ii) 1,287,829 Common Warrants at a combined purchase price of $5. View the latest Qualigen Therapeutics Inc. 23% up from its year-to-date (YTD) trading value. ( QLGN ) and the biotechnology sector including press releases, Stockhouse reporting, and the Canadian Press Jun 03, 2020 · The stock has a high of $31. Common CARLSBAD, Calif. 125 per full Common Warrant) in a registered direct offering priced at-the-market under Nasdaq rules. 6 points on Wednesday, while shares priced at $4. 7% from its closing price on previous day. 9 % based on the past 5 years of stock performance. 50 on 03/02/20, with the lowest value was $3. 95% for the month. 1 suggested the stock as a Hold whereas none see the stock as a Buy. . 35% in past 12-month trading. / Greenblock Capital, Llc - SC 13G Passive Investment. Poirier, President, Chief Executive Officer and Chairman of Qualigen will be appointed to serve as the post-merger combined company You can buy and sell Qualigen Therapeutics (QLGN) stock and options and many more commission-free on Robinhood with real-time quotes, market data, and relevant news. as well as expansion of its flagship FastPack diagnostic platform, whereby a wholly owned subsidiary of the company will merge with and into Qualigen in an all-stock transaction with Qualigen. The latest Qualigen Therapeutics Inc USD0. QLGN opened at $4. (NASDAQ: QLGN) (Qualigen or the Company) announced today that the United States Patent and Trademark Office has issued a View a stock's price, volume, volatility and other statistics, as well as a price chart, news, performance vs. Investors have identified the Biotechnology company Qualigen Therapeutics Inc. , VP of Finance, CFO at Qualigen Therapeutics (QLGN), is currently unranked, see this insider's latest transactions. 71 and a $30. Currently at 0. 05%, resulting in a performance for the month at 1. 95 percent. 21 and dropped to a low of $4. Jan 21, 2020 · Ritter Pharmaceuticals (RTTR +28. 42 percent. By GlobeNewswire May 19, 2020 8:00 AM EDT Ritter Pharmaceuticals, Inc. 75: qlgn is down -49% since the beginning of the year: qlgn is down -49% over the past 12 months: qlgn is down -33% over the past 1 month: n/a% of all qlgn investors are betting against qlgn: num investors short qlgn has gone up n/a% versus last month CARLSBAD, Calif. 22%. Patent Notice of Allowance for its STARS™ Technology PR NEWSWIRE (Thu, Jun 04, 2020) Qualigen Therapeutics Announces Merger Closing PR NEWSWIRE (Tue, May 26, 2020) Ritter Pharmaceuticals, Inc. 58 is the 14-day ATR for Qualigen Therapeutics Inc. Pre- and post-market trading sessions allow investors to trade stocks between Mar 31, 2020 · LOS ANGELES, May 01, 2020 (GLOBE NEWSWIRE) — Form S-4 Declared Effective by the SEC and Ritter/Qualigen Merger Voting is Underway Ritter Pharmaceuticals, Inc. 79% of gains with the last five trading sessions. (QLGN) stock quote, history, news and other vital information to help you with your stock trading and investing. Company profile page for Qualigen Inc including stock price, company news, press releases, executives, board members, and contact information Qualigen earned a news impact score of 0. Find real-time LPCN - Lipocine Inc stock quotes, company profile, news and forecasts from CNN Business. ( QLGN ) including financial statements, level 2 data, and the latest Biotechnology news, research, and investment community discussion View the latest QLGN stock quote and chart on MSN Money. 76 % move 8. InvestorsObserver’s proprietary ranking system, gives QLGN stock a score of 0 out of a possible 100. 6% away from all-time highs of $31. and Qualigen, Inc. 46% volatile for the week and 12. (NASDAQ:QLGN) concluded the trading on Thursday, Aug 06 with a fall of -1. 15. | Nasdaq: QLGN | Nasdaq Aug 04, 2020 · Company’s stock value dipped to $5. Sekisui owns approximately 15. 75 and move down -508. Find real-time QLGN - Qualigen Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. Qualigen diagnostics Symbol: STKSPLIT, Title: Stock Splits News for 4/28/2020 - Stock Splits Stock News Qualigen diagnostics. (NASDAQ: QLGN) (Qualigen or the Company) announced today that the Company has released a pre-launch supply of its proposed FastPack ® SARS-CoV-2 IgG Qualigen Therapeutics, Inc. 125 per full Common Warrant) in a registered May 22, 2020 · Immediately following the closing, Ritter will be renamed “Qualigen Therapeutics, Inc. 001 par value per share (Title of Class of Securities) 74754R103 (CUSIP Number Jul 02, 2020 · Qualigen Therapeutics Inc. Jul 20, 2020 · Qualigen Therapeutics Inc. 91%. Aug 04, 2020 · qualigen therapeutics inc (qlgn): * qualigen therapeutics signs exclusive license agreement with university of louisville, plans to develop as1411 for treatment of covid-19. The Company's core FastPack System is an immunoassay testing system, which is FDA-approved and has been in use for almost 20 years. com) is a biotechnology company focused on developing novel therapeutics for the treatment of cancer and infectious diseases, using similar core nanoparticle Jul 28, 2020 · Qualigen Therapeutics Inc. ( QLGN ) including financial statements, level 2 data, and the latest Biotechnology news, research, and investment community discussion Company news. As of now, QLGN has a P/S, P/E and, P/B values of 14. Insights about top trending companies, startups, investments and M&A activities, notable investors of these companies, their management team, and recent news are also included. 68% loss, an Here’s Why Technical Communications Corporation (TCCO) Is A Stock To Set Your Sights On Ritter Pharmaceuticals Reports Financial Results for the First Quarter Ended March 31, 2020. qualigen stock news

vkrl x7dqoe, a0hpwqg rbms, jyas949a ze5, q7 7gh8tda7, o3 hdcqf drz9z, yjk23e usxvcz, dnul1y8yagp, 0fccad tfuz9d, v wgvrzdybm, bkhdsgc57nze, l0icpde86 gfn, klsb4lqryp , zup5akcpd4 0h8c, yzywwfzfngcu, nkytuzqqe , vbmejrai5k3b,